Products

Virus Packaging

Cloning Services

AAV quality services

Resources

About US

Current Location:Home > Products > Reagent

Viral Transduction Enhancer




一、Product Introduction:

Product Name: Viral Transduction Enhancer;

Abbreviation: ADV-HR

Cat. No:FH880805

Specification: Concentration 1mg/ mL; Volume 1ml

Storage conditions: It is recommended to store at -20℃ after aliquoting, and store at 4℃ within a week.


Reminder: Avoid repeated freezing and thawing! Repeated freezing and thawing will seriously affect the experimental results, please use it within a week!



二、Product Description:


The Viral Transduction Enhancer(shortened to ADV-HR) enhance virus adsorption on target cell membranes, thereby increasing adenovirus and lentivirus gene transfer efficiency.



三、Viral Transduction Enhancer Protocol :


3.1 Directly adding the virus to the cell culture, suitable for easy-to-transfect cells

1. For viral transduction, add ADV-HR directly into cell culture dish/well/flask. Shake gently to ensure homogenous spread.

2. The follow-up steps depend on the virus type and individual experiment.


3.2 Incubating cells, virus and ADV-HR before transfering the this mixture to complete medium, suitable for hard-to-transfect cells

Take the 6-well plate as an example:

3.2.1 Preparation of ADV-HR transduction mixtures in a 1.5ml EP tube are given below(Total volume: 100ul):

① ADV-HR

X µ L

② Virus

Y µ L

③ Cell suspension

(100-X-Y) µL (containing 1.0×10E6 cells)

ADV-HR dosage X refer to pre-experimental results; Virus dosageY is calculated based on virus titer, cell culture formats, and multiplicity of infection (MOI) .

3.2.2 Mix gently by pipetting up and down, and incubate at 37℃ in  for 0.5-1 hours.

3.2.3 Gently resuspend the cells using a pipette, and place directly into the freshly prepared 6-well plate. Gently swirl and place into a 5% CO2 incubator at 37℃.

3.2.4 The follow-up steps depend on the virus type and individual experiment.



四、Examples-The lentiviral transduction efficiency in HepG2 & CNE2 cells with ADV-HR